Allergan buys MAP for $958m
Friday, January 25, 2013 - 11:40
in Biology & Nature
Deal strengthens Allergan's position in neurology with Levadex for treating migraine
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via